Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 2.1B | 2.1B | 1.8B | 1.7B |
Cost of revenue | 832M | 1.1B | 822M | 718M |
Gross profit | 1.3B | 1.0B | 958M | 974M |
Operating expense | ||||
Research & development | 222M | 216M | 179M | 170M |
Selling general and admin | 281M | 274M | 228M | 220M |
Other operating expenses | — | -12M | — | — |
Operating income | 807M | 526M | 551M | 584M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 786M | 543M | 560M | 616M |
Tax provision | 165M | 78M | 112M | 128M |
Net income | 621M | 464M | 448M | 488M |
Basic EPS | 6.4 | 4.7 | 4.6 | 5.0 |
Diluted EPS | 6.4 | 4.7 | 4.6 | 5 |
Basic average shares | 97.6M | 97.7M | 97.6M | 97.6M |
Diluted average shares | 97.7M | 97.7M | 97.6M | 97.6M |
EBITDA | 807M | 526M | 551M | 584M |
Net income from continuing op. | 786M | 543M | 560M | 616M |
Minority interests | 0 | -5M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |